AMGN
Price:
$320.56
Market Cap:
$172.25B
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal nu...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1983-06-17
Stock Exchange
NASDAQ
Ticker
AMGN
According to Amgen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 225.59B. This represents a change of 12.28% compared to the average of 200.91B of the last 4 quarters.
The mean historical Enterprise Value of Amgen Inc. over the last ten years is 161.85B. The current 225.59B Enterprise Value has changed 13.84% with respect to the historical average. Over the past ten years (40 quarters), AMGN's Enterprise Value was at its highest in in the June 2024 quarter at 220.36B. The Enterprise Value was at its lowest in in the September 2015 quarter at 133.24B.
Average
161.85B
Median
157.16B
Minimum
140.72B
Maximum
207.76B
Discovering the peaks and valleys of Amgen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 29.47%
Maximum Annual Enterprise Value = 207.76B
Minimum Annual Increase = -6.47%
Minimum Annual Enterprise Value = 140.72B
Year | Enterprise Value | Change |
---|---|---|
2023 | 207.76B | 20.36% |
2022 | 172.62B | 12.41% |
2021 | 153.55B | -4.89% |
2020 | 161.45B | -4.87% |
2019 | 169.71B | 9.03% |
2018 | 155.66B | -1.89% |
2017 | 158.66B | 12.75% |
2016 | 140.72B | -6.47% |
2015 | 150.46B | 1.74% |
2014 | 147.89B | 29.47% |
The current Enterprise Value of Amgen Inc. (AMGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
177.98B
5-year avg
173.02B
10-year avg
161.85B
Amgen Inc.’s Enterprise Value is less than Merck & Co., Inc. (325.14B), less than AbbVie Inc. (399.11B), greater than Gilead Sciences, Inc. (118.58B), less than Johnson & Johnson (412.32B), greater than Bristol-Myers Squibb Company (146.44B), less than Pfizer Inc. (230.24B), less than Eli Lilly and Company (883.63B), greater than Biogen Inc. (34.19B),
Company | Enterprise Value | Market cap |
---|---|---|
325.14B | $298.70B | |
399.11B | $341.61B | |
118.58B | $98.01B | |
412.32B | $395.70B | |
146.44B | $98.73B | |
230.24B | $161.84B | |
883.63B | $857.96B | |
34.19B | $29.25B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amgen Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amgen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Amgen Inc.'s Enterprise Value?
What is the highest Enterprise Value for Amgen Inc. (AMGN)?
What is the 3-year average Enterprise Value for Amgen Inc. (AMGN)?
What is the 5-year average Enterprise Value for Amgen Inc. (AMGN)?
How does the current Enterprise Value for Amgen Inc. (AMGN) compare to its historical average?